Skip to main content

Day: August 18, 2021

BioPorto Announces Q2 2021 Report

August 18, 2021Announcement no. 14Q2 2021 Report Highlights Solid revenue growth in the first half of 2021 In the first half of 2021, BioPorto’s revenue grew by 20% measured in USD and 11% when measured in DKK, driven by strong sales of antibodies and higher research use only (RUO) sales of The NGAL Test™ in the US. In the second quarter of 2021, revenue from antibodies was up 118% and RUO sales of The NGAL Test in the US increased 84% in USD and 68% in DKK. Enrollment in the US clinical trial of The NGAL Test continues; interim re sults expected end‐August 2021 Enrollment of patients in the study to support a De Novo 510(k) application for The NGAL Test for use in pediatrics has progressed well in the second quarter of 2021. During this period BioPorto also brought on board several new trial sites, contributing to further progress in...

Continue reading

Infectious Disease POC Diagnostics Market Size | Is Expected to Reach USD 3.96 Billion by 2028 while Exhibiting an Impressive CAGR of 17.2%

Key Prominent Players Covered in the Infectious Disease Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland) , Thermo Fisher Scientific Inc. (Massachusetts, U.S.) , Abbott Laboratories (Illinois, U.S) , Quest Diagnostics Incorporated (New Jersey, United States) , BD (Franklin Lakes, U.S) , bioMérieux SA (Marcy l’Etoile, France) , Cardinal Health, Inc. (Ohio, U.S) , Mesa Biotech (California, U.S) , Cepheid (California, U.S) , Trinity Biotech (Bray, Ireland) , Quidel Corporation (San Diego, U.S.) , Bio-Rad Laboratories Inc. (California, U.S) , Other Players Pune, India, Aug. 18, 2021 (GLOBE NEWSWIRE) — The global Infectious Disease POC Diagnostics Market size is expected to gain momentum by reaching USD 3.96 billion by 2028 while exhibiting an impressive CAGR of 17.2% between 2021...

Continue reading

AS Tallink Grupp will hold an Investor Webinar to introduce the Public Offering of Shares

AS Tallink Grupp will introduce the Public Offering of Shares in Estonia and Finland in an investor webinar. All shareholders and interested parties are invited to join the webinar, scheduled to take place on 23 August 2021 at 15:00 (EET). The webinar will be held in English and prior registration is required. The questions asked in Estonian or Finnish will be addressed in the respective language. The webinar will be attended by the Chairman of the Management Board Paavo Nõgene, Members of Management Board Harri Hanschmidt and Margus Schults and Financial director Joonas Joost. Questions can also be sent prior to the webinar by e-mail to: investor@tallink.ee. How to join the webinar?To join the webinar, please register by 23 August 2021 at 14:30 (EET) latest via the following link: https://attendee.gotowebinar.com/register/296706928249645326. When...

Continue reading

AS Tallink Grupp will hold an Investor Webinar to introduce the Public Offering of Shares

AS Tallink Grupp will introduce the Public Offering of Shares in Estonia and Finland in an investor webinar. All shareholders and interested parties are invited to join the webinar, scheduled to take place on 23 August 2021 at 15:00 (EET). The webinar will be held in English and prior registration is required. The questions asked in Estonian or Finnish will be addressed in the respective language. The webinar will be attended by the Chairman of the Management Board Paavo Nõgene, Members of Management Board Harri Hanschmidt and Margus Schults and Financial director Joonas Joost. Questions can also be sent prior to the webinar by e-mail to: investor@tallink.ee. How to join the webinar?To join the webinar, please register by 23 August 2021 at 14:30 (EET) latest via the following link: https://attendee.gotowebinar.com/register/296706928249645326. When...

Continue reading

19/2021 Green Hydrogen Systems – Interim report for Q2 2021

Following the successful listing on Nasdaq Copenhagen in June 2021, Green Hydrogen Systems delivers strong order backlog growth while scaling the production facility to 400 MW executing as planned in line with the targets towards 2025. Performance highlights for Q2 2021Converting sales pipeline to firm customer orders with backlog increase of 6.2 MW or +1,000% compared to Q2 2020 Revenue from customer contracts of DKK 1.6 million compared to DKK 0.3 million in Q2 2020 Gross profit of DKK 1.2 million compared to DKK 0 million in Q2 2020 Strong investor support in the recent listing of Green Hydrogen Systems at Nasdaq Copenhagen resulting in a solid cash position of DKK 1,121 million Positive commercial traction:Three firm customer orders in Q2 2021 and further two orders in July and August 2021 totaling 4.3 MW confirming Green Hydrogen...

Continue reading

Notice on public offering of shares of AS Tallink Grupp in Estonia and Finland (in the form of Finnish share depositary receipts)

Aktsiaselts Tallink Grupp (the Company) hereby announces a public offering of the new shares of the Company in Estonia and Finland (in Finland in the form of the Finnish share depositary receipts, FDRs) (the Offering).  The Offering is conducted on the basis of the prospectus approved by the Estonian Financial Supervision and Resolution Authority (hereinafter the EFSA) on 16 August 2021 that is published on the date of this announcement on the web pages of the Company (https://www.tallink.com/investors/stock-exchange/2021-offering), Nordnet Bank AB Finnish Branch (www.nordnet.fi/fi/tallink) and the EFSA (https://fi.ee/en/investment/registers/registered-public-offerings/approved-prospectuses) (hereinafter Prospectus). The public offering of the new shares is carried out only in Estonia and Finland (in the form of FDRs) and not in any other...

Continue reading

Notice on public offering of shares of AS Tallink Grupp in Estonia and Finland (in the form of Finnish share depositary receipts)

Aktsiaselts Tallink Grupp (the Company) hereby announces a public offering of the new shares of the Company in Estonia and Finland (in Finland in the form of the Finnish share depositary receipts, FDRs) (the Offering).  The Offering is conducted on the basis of the prospectus approved by the Estonian Financial Supervision and Resolution Authority (hereinafter the EFSA) on 16 August 2021 that is published on the date of this announcement on the web pages of the Company (https://www.tallink.com/investors/stock-exchange/2021-offering), Nordnet Bank AB Finnish Branch (www.nordnet.fi/fi/tallink) and the EFSA (https://fi.ee/en/investment/registers/registered-public-offerings/approved-prospectuses) (hereinafter Prospectus). The public offering of the new shares is carried out only in Estonia and Finland (in the form of FDRs) and not in any other...

Continue reading

Sievi Capital Plc and Boreo Plc Consider Combination

SIEVI CAPITAL PLC INSIDE INFORMATION 18 AUGUST 2021 AT 9:30 A.M. EEST NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW SIEVI CAPITAL PLC AND BOREO PLC CONSIDER COMBINATION Today, the Boards of Directors of Sievi Capital Plc (“Sievi”) and Boreo Plc (“Boreo”) signed a letter of intent (“Letter of Intent”), pursuant to which the parties are looking into a potential combination between Boreo and Sievi (“Contemplated Combination”). The Contemplated Combination would result in creation of one of the leading growth platforms for small and medium sized companies in Helsinki Stock Exchange (the “Future Company”). For 2020, initial estimates of the combined turnover (IFRS) of Sievi, including Sievi’s portfolio companies, and Boreo is approximately MEUR...

Continue reading

Quadient Announces Partnership with UiPath to Further Enhance and Automate Omnichannel Customer Communications

Paris, August 18, 2021 Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, announced today it has partnered with leading enterprise automation software company UiPath. Quadient’s partnership and integration with UiPath helps enterprises digitally transform customer experiences while maintaining regulatory compliance on customer communications, boosting productivity, reducing cost and improving employee satisfaction. The partnership brings together Quadient’s market-leading Inspire software suite, which enables enterprises to create and deliver personalized customer communications across all digital and traditional channels, and the benefits of using the UiPath Platform for end-to-end automation. The UiPath Platform combines its leading Robotic Process...

Continue reading

Allarity Therapeutics Elaborates on the Contents of the Meeting Agenda for the Extraordinary General Meeting Announced on August 16, 2021

Press Release Hørsholm, Denmark (August 18, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) yesterday published a notice to convene an Extraordinary General Meeting on August 31, 2021. The Company hereby further elaborates on the information provided in the notice. Based on questions received from various shareholders with regard to the agenda item for the Extraordinary General Meeting to authorize the Board of Directors to purchase treasure shares in the market, Allarity hereby announces that this authorization is solely requested as a preparatory step towards the contemplated Recapitalization Share Exchange and a move to a listing on the Nasdaq Stock Market (New York, U.S.) as previously announced on May 21, 2021. It is currently expected that the Recapitalization Share Exchange and listing in the U.S., if approved by...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.